-
She does make some very good points here with bringing in additional revenue to allow the FDA to inspect more over seas manufacturing facilities. She also states that branded companies as well as generic drug companies both need need more attention with inspections. Currently in the US factories...
-
If you were a patient taking phenobarbital for seizures and have the wrong drug you may not get the the desired relief with hydrocodone. Also this is a combination drug with acetaminophen so concerns for those with seizures and any liver dysfunctions. This looks not to be too big but not...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Feb 10 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, FDA, Generic Drugs, Recalls, Vicodin, Acetaminophen, bar coding, seizures, Qualitest, phenobarbital, Hydrocodone Bitartrate
-
This is a good deal for developing nations getting drugs at an affordable price. This makes Johnson and Johnson the first pharma company to license generic copies before approval is even given. J and J licensed the drug for use in 48 countries listed as least developed countries to include...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sun, Jan 30 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, Pills, FDA, Generic Drugs, Patents, Johnson and Johnson, AIDS, licence, Tibotec, regulators
-
Well the patients in the US have to wait a little longer and it is amazing that in Europe as the title suggests has generics available. In May of 2010 Plavix was given a ruling by the FDA to establish a black box warning too. FDA Gives Plavix New Box Warning Relating to Metabolization in...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Jan 26 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Pharma, Pills, FDA, Generic Drugs, Marketing, Patents, Europe, Plavix, Sanofi-Aventis, expire, Bristol-Myers Squibb
-
Dr. Reddy is located in India and the FDA has now approved their generic version of Lansoprazole for the treatment of ulcers and Dr. Reddy states the product should be available shortly. BD New Delhi, Oct 16 (PTI) Dr Reddy''s Laboratories today said it has received an approval from...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sun, Oct 17 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, FDA, Generic Drugs, Takeda, ulcers, Prevacid, Dr. Reddy, Lansoprazole
-
Teva is probably one of the most interesting pharmaceutical companies out there as they are pretty much generic with the exception of some of their own research products. Recently in the news the company quit manufacturing propofol here in the US so now our supply comes from Europe. Teva gets FDA...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Oct 15 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, FDA, Generic Drugs, Breast Cancer, Teva, Arimidex, Anastrozole, Buehler
-
Well thank you FDA for bringing this to our attention as clinical trials today versus what they were when the drug was created has grown and only 1% of our over all sales are attributed to this drug, so we’ll just throw in the towel here and take the drug off the market. The drug was approved in...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Aug 17 2010
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, drugs, healthcare, FDA, Generic Drugs, Shire, ProAmatine, low blood pressure
-
The FDA is not alone in their thinking here either as earlier this year Bill Gates invested in drug simulation software too. According to the press release an additional 10 licenses were purchased. Bill Gates Invests In Software Company That Predicts and Helps Generate Creating New Drugs...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Aug 13 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, healthcare, microsoft, FDA, Generic Drugs, software, Bill Gates, Algorithms, Drug Development, healthcare reform, simulations, SimulationsPlus
-
Most individuals who have searched to find a generic drug have had to go to Canada and outside the US for this drug that is used for treating breast cancer so this is good news with an affordable alternative. BD Teva Pharmaceutical Industries Ltd. said Monday the Food and Drug Administration...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Jun 28 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, FDA, Generic Drugs, Breast Cancer, Teva, Arimidex, AstraZeneca', Anastrozole
-
This add one more generic version of Flomax available that will be available for sale almost immediately. BD The Food and Drug Administration granted marketing approval Wednesday to Teva Pharmaceutical Industries for a generic version of Flomax, a drug used to treat enlarged prostate. Flomax...
-
Last December Teva announced they were going to ask so now it looks like the FDA has given the ok to review. Due to lack of whatever you want to call it these days in Congress, there are no provisions where a generic version of a biotech drug (aka biosimilars) can be approved and the drug is viewed...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Feb 2 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, healthcare, Cancer, FDA, Generic Drugs, Congress, Merck, Politics, Amgen, Intellectual property, Teva, Drug approvals, drugs discounts, biosimilar
-
A disappointment for Merck and this is not the only patent tied up in the legal system today, Singulair is another one where the patent is being questioned. Merck plans to appeal the case according to the article, ho hum, more legal cases to drive up the cost of the medicine we need. BD ...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Jan 26 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, Pharma, FDA, Generic Drugs, Merck, Patents, Amgen, Intellectual property, Teva, legal cases
-
The cost of the purple pill is enough to give one heartburn. Consumer reports is trying to help you out with some affordable over the counter alternatives. Astra Zeneca already cut a deal with Ranbaxy to delay it’s release of a generic version of the drug. Who’s on the list for the next deal...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sun, Jan 17 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, FDA, Generic Drugs, Teva, Gerd, FTC, healthcare reform, drug deals, Astra Zenaca, purple pill, Nexium, heartburn
-
This is a guest post from Shannon Wills and I welcome her post to the Medical Quack today as she has some information to add regarding generic drugs. Be sure to visit her links at the end of the post for more information. BD Their chemical compositions are similar and they are supposed...
-
Wyeth is claiming there are 2 different versions and the generic would not be the latest version manufactured by the generic company Orchid, which would endanger patients with not receiving enough medication to clear infections. There was a case not too long ago where the generic company had issues...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Sep 23 2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, FDA, Generic Drugs, Wyeth, HHS, Pfizer, Antibiotics, Lawsuits, Orchid, Zosyn